ID   MHHi015-A
AC   CVCL_ZX23
SY   hCD34iPSC16; hCD34-iPSC16
DR   BioSamples; SAMEA6285351
DR   hPSCreg; MHHi015-A
DR   Wikidata; Q102114531
RX   PubMed=24290698;
RX   PubMed=29249666;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX24 ! MHHi015-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=24290698; DOI=10.1016/j.biomaterials.2013.11.024;
RA   Ackermann M., Lachmann N., Hartung S., Eggenschwiler R., Pfaff N.,
RA   Happle C., Mucci A., Gohring G., Niemann H., Hansen G., Schambach A.,
RA   Cantz T., Zweigerdt R., Moritz T.;
RT   "Promoter and lineage independent anti-silencing activity of the A2
RT   ubiquitous chromatin opening element for optimized human pluripotent
RT   stem cell-based gene therapy.";
RL   Biomaterials 35:1531-1542(2014).
//
RX   PubMed=29249666; DOI=10.1016/j.stemcr.2017.11.011; PMCID=PMC5768914;
RA   Neehus A.-L., Lam J., Haake K., Merkert S., Schmidt N., Mucci A.,
RA   Ackermann M., Schubert M., Happle C., Kuhnel M.P., Blank P.,
RA   Philipp F., Goethe R., Jonigk D., Martin U., Kalinke U., Baumann U.,
RA   Schambach A., Roesler J., Lachmann N.;
RT   "Impaired IFNgamma-signaling and mycobacterial clearance in
RT   IFNgammaR1-deficient human iPSC-derived macrophages.";
RL   Stem Cell Reports 10:7-16(2018).
//